Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (271-280 of 596) with videos related to

Pageof 60
Sort By:
Cell Reports|February 2, 2018
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast CancerAgnieszka K Witkiewicz, Sejin Chung, Rachel Brough, et al.
The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.
The Australian and New Zealand Journal of Surgery|March 1, 1988
Experience with the Nesbit procedure in the treatment of penile curvatureG R Watters, Z S Wisniewski, C M Earle, et al.
Thrombosis and Haemostasis|October 7, 2009
Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?Natalie Urwyler, Lukas P Staub, Dominik Beran, et al.
British Journal of Cancer|March 15, 2012
Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysisH Verry, S J Lord, A Martin, et al.
Therapeutic Advances in Medical Oncology|August 11, 2018
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysisKatrin M Sjoquist, Sarah J Lord, Michael L Friedlander, et al.
Biochemical and Biophysical Research Communications|May 24, 1996
The polyether bistratene A activates protein kinase C-delta and induces growth arrest in HL60 cellsG Griffiths, B Garrone, E Deacon, et al.
Paraplegia|April 1, 1992
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injuryC M Earle, E J Keogh, J K Ker, et al.
Southern Medical Journal|April 1, 1993
The Texas Breast Screening Project: Part I. Mammographic and clinical resultsG N Peters, V G Vogel, W P Evans, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Pageof 60

Showing results (271-280 of 596) with videos related to

Sort By:
Pageof 60
Cell Reports|February 2, 2018
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast CancerAgnieszka K Witkiewicz, Sejin Chung, Rachel Brough, et al.
The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.
The Australian and New Zealand Journal of Surgery|March 1, 1988
Experience with the Nesbit procedure in the treatment of penile curvatureG R Watters, Z S Wisniewski, C M Earle, et al.
Thrombosis and Haemostasis|October 7, 2009
Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?Natalie Urwyler, Lukas P Staub, Dominik Beran, et al.
British Journal of Cancer|March 15, 2012
Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysisH Verry, S J Lord, A Martin, et al.
Therapeutic Advances in Medical Oncology|August 11, 2018
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysisKatrin M Sjoquist, Sarah J Lord, Michael L Friedlander, et al.
Biochemical and Biophysical Research Communications|May 24, 1996
The polyether bistratene A activates protein kinase C-delta and induces growth arrest in HL60 cellsG Griffiths, B Garrone, E Deacon, et al.
Paraplegia|April 1, 1992
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injuryC M Earle, E J Keogh, J K Ker, et al.
Southern Medical Journal|April 1, 1993
The Texas Breast Screening Project: Part I. Mammographic and clinical resultsG N Peters, V G Vogel, W P Evans, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Pageof 60